Connect with us

Cannabis News

If Your Teen Smoked Weed a Few Times, No, He or She Will Not Be Dumber for It

Published

on


teens who smoke weed occassionaly not dumb

The harmful effects of cannabis use throughout adolescence, when the brain is going through a vital developmental stage, are well acknowledged. A comprehensive study on cannabis is still being conducted, though, and there are still many unanswered questions that scientists are working to fill.

 

A new study by Portuguese researchers that was published in the Journal Psychopharmacology aims to close some of these gaps by concentrating on the sporadic cannabis usage of adolescent subjects.

 

In the end, the study’s conclusions confirm that, as compared to their counterparts who do not use cannabis, teenagers who use it sometimes have no appreciable changes in cognitive performance.

 

Investigating Gaps in a Well-Studied Area

 

Researchers embark on a journey to dissect prevalent barriers in cannabis research, particularly its impact on brain functions. Delving into the realms of psychology, neurocognition, and brain dynamics during adolescence, they highlight the alterations in the endocannabinoid system, emphasizing its connection with stress and anxiety regulation, which potentially heightens vulnerability to emotional and anxiety disorders among adolescents.

 

Acknowledging the discrepancies in existing literature, the researchers advocate for further exploration using longitudinal research methodologies.

 

“Many adolescents partake in sporadic cannabis use, with non-problematic usage being significantly more common than instances of Cannabis Use Disorder,” the authors emphasize. “Hence, it’s imperative to scrutinize the neurocognitive and psychological ramifications among adolescents escalating to heavier cannabis use and those maintaining minimal consumption.”

 

Leveraging data from the extensive longitudinal IMAGEN study cohort, primarily characterized by infrequent to moderate cannabis usage, the study probes into whether pre-existing variations in reward-related brain activity, psychopathology, and cognitive performance predict cannabis initiation. Additionally, it examines whether cannabis usage leads to compromised levels of functioning in these domains and, if so, whether these impairments recover upon cessation of use.

 

Exploring the Impact of Occasional Cannabis Use on Adolescent Behavior

 

The study recruited participants from eight locations across England, Ireland, France, and Germany. At the baseline measurement, participants averaged 14 years of age, 19 at the first follow-up, and 22 at the second follow-up. Eligible participants reported either no or low risk of alcohol use and nicotine dependence at the baseline.

 

Individuals who had used any illicit substance more than twice or had a total of more than eight uses of illicit substances in their lifetime were excluded from the sample, resulting in 1,946 eligible participants.

 

Throughout the study, participants completed various questionnaires to assess substance use, psychopathology, and cognition. Additionally, researchers utilized the Puberty Development Scale and a scale measuring family stressors experienced by participants.

 

A cognitive task was administered at each time point, where participants were instructed to respond promptly to targets by pressing a button. Depending on their performance, participants could earn two, ten, or no points, with the incentive of receiving candy for every five points earned.

 

The research primarily focused on examining brain responses during anticipation of gains and feedback on successful and unsuccessful trials. Statistical analyses were also conducted to determine if baseline characteristics predicted later cannabis use, with logistic regression analyses comparing cannabis users at the first follow-up with non-users.

 

Minimal Adolescent Cannabis Use: Absence of Cognitive Decline

 

Examining the initial inquiry into baseline predictors of cannabis initiation at age 19, researchers found that participants with higher scores in conduct problems and lower scores in peer-related issues at age 14 were more likely to use cannabis at age 19. However, neither the anticipation of rewards nor the processing of feedback predicted cannabis use at 19 years old.

 

In comparing cannabis users to non-users, researchers observed that the cannabis-using cohort had higher scores at ages 14 and 19, as well as increased hyperactivity/inattention scores at age 19. Nevertheless, there were no statistically significant differences detected in cognitive function, psychopathology, or brain activity.

 

“We did not identify any cognitive impairment in light cannabis users, neither before nor after cannabis use onset,” researchers assert. “Indeed, despite the broad association between adolescent cannabis use and neurocognitive impairment, our findings suggest that these effects are minor and may not have clinical significance.”

 

At age 22, persistent cannabis users exhibited “significantly higher” conduct problems compared to the control group. However, due to the lack of significant disparities in cognitive function and brain activity, the hypothesis regarding recovery with abstinence was not tested, as researchers note.

 

The authors suggest that a larger sample size could enhance the robustness of statistical analyses and findings. They also mention that a greater representation of heavy cannabis users would improve the generalizability of results, despite the similarity in cannabis use patterns with previous studies that also found no group differences in reward-related brain activity.

 

Researchers emphasize that these findings may only apply to the effects experienced by low-frequency cannabis users, not heavy users or those with cannabis use disorder.

 

“The study design allowed for an examination of potential preexisting differences in brain activity, cognitive function, and psychological symptoms in a developmental sample of adolescents who would engage in light cannabis use in the future,” the authors conclude.

 

“We found no evidence of preexisting individual differences in reward processing or specific cognitive domains,” they continue. “However, cannabis-naïve adolescents with conduct problems and those who were more socially connected with their peers appear to be at a higher risk of engaging in persistent cannabis use in the future. Additionally, cannabis use during adolescence may lead to the development of hyperactivity and inattention symptoms.”

 

Bottom Line

 

The study indicates that occasional cannabis use during adolescence may not result in notable cognitive decline. Despite potential risk factors such as conduct problems and strong social ties with peers correlating with persistent cannabis use, the research did not detect significant impairment in cognitive function. However, these findings warrant further investigation with larger sample sizes and representation of heavy cannabis users to validate the results. Understanding the impact of cannabis use on adolescent development is crucial, and while this study provides valuable insights, continued research is necessary to comprehensively assess the effects of cannabis on cognitive health during this critical stage of brain development.

 

CANNABIS SLOWS COGNITIVE DECLINE IN THE ELDERLY, READ ON…

CANNABIS SLOWS COGNITIVE DECLINE

CANNABIS SLOWS COGNTIVE DECLINE IN THE ELDERY SAYS NEW STUDY!



Source link

Cannabis News

Why Falling THC Test Results Matter

Published

on

By


The fluctuating levels of reported THC (tetrahydrocannabinol) in cannabis products have sparked discussions and concerns within the industry. Contrary to popular belief, the decline in tested THC levels does not necessarily indicate a decrease in potency. We examine the reasons behind this phenomenon, exploring how changes in testing protocols, sample selection, and laboratory practices contribute to these findings. As an industry, we cannot lose sight of the importance of standardized testing practices to ensure transparency and reliability in the market.

Just a few years ago, Justin Bieber boasted that he gets his weed from California. But recent testing indicates that the level of THC in California cannabis has fallen dramatically over the last year. Is it time for Bieber to find a new source? Probably not—but the industry shouldn’t shrug this news off either. Let’s look at what’s happening with THC testing across the country and consider what it means for consumers, cannabis businesses, regulators, and the industry as a whole.

Yes, tested THC levels are falling. Here’s why

California isn’t the only state that’s seen a drop in THC test levels. One recent article analyzed the THC percentage for 23 cannabis flower samples sold in Colorado, finding that the vast majority, 18 of 23, tested lower than the claimed range. Three samples contained less than half as much THC as their sellers claimed. Does that mean that weed is getting weaker? Not at all. Falling test results are far more likely due to changes in testing than to changes in the true levels of THC in cannabis plants.

Some of this has to do with sample selection. Every individual plant has a distinct genetic profile. Even in a controlled environment, each plant is influenced by the precise amount of light, nutrients, and water it receives (“epigenetic factors”). Some plants within a given crop will always be superior in quality, just as some flowers on any given plant will be average, while others will be exceptional. Cannabis producers should be taking a random sample from each batch for testing, but it’s often easy to—intentionally or otherwise—select more test samples from the best exemplars than from the run of the mill.

But it’s not all sampling error; labs may produce different test results from the same sample due to the protocols they use, or the stringency of their methods. Do some producers “lab shop” to find a lab that will report higher potency results? Almost certainly. Do some labs inflate their results to try to win more business? Again, almost certainly.

As states have gotten stricter about policing both sample selection and lab accuracy, tested THC results have fallen. But that doesn’t mean the product is any less potent.

Cannabis potency is complex. Does THC testing matter?

Cannabis isn’t as straightforward as something like alcohol. There’s no single value that determines how “strong” a product is or what effects it’ll have on a consumer. The potency of any particular cannabis product isn’t driven just by its level of THC but also by its overall cannabinoid and terpene profiles, the form of consumption, and the individual traits of the person using it.

Why does THC testing even matter, then?

At a consumer level—especially for those who use marijuana medically—differences in THC levels may influence the amount they consume, and the therapeutic or recreational benefits they receive. Consumers may also use THC test results as a benchmark for quality or value and therefore the price that they’re willing to pay for a product.

At the state level, discrepancies in lab results have led to heightened scrutiny. California has been fining cannabis businesses and suspending operator licenses for overreporting THC content, while Massachusetts is sending out “secret shoppers” to check on producers and dispensaries.

More importantly, though, inflated THC test levels damage everyone’s trust in the cannabis industry. THC isn’t the only thing marijuana is tested for, or even the most important; consumers, businesses, and regulators should all be able to trust the processes and results of tests for pesticides, toxins, and contaminants like mold. But why should anyone believe those numbers are reliable if THC levels are consistently overreported?

That leaves us caught in a double bind: consistency is all but impossible to achieve within the current fragmented legal structure, but without consistency, the industry isn’t taken seriously.

It takes an expert to legally navigate the cannabis industry

Every ethical player in the cannabis industry—from growers to retailers to consumers—would benefit from uniform standards in testing methods, controls, regulations, and oversight (not to mention legalized banking!). As it stands, cannabis businesses must try to reconcile a morass of conflicting, often confusing guidance, paying exorbitant taxes — at least for now –without receiving many of the benefits that other businesses receive. We have been working with cannabis industry businesses to navigate these issues for well over a decade. Give us a call if you think we could help.



Source link

Continue Reading

Cannabis News

How Do You Get THC Out of Your System Fast?

Published

on

By


how to get rid of thc fast

Let’s imagine you just found out you have a surprise drug test at work and you “may or may not” need to flush THC out of your system as fast as possible by, say, Monday.

 

Detoxing from cannabis involves waiting until all traces of the substance have cleared the body, a process influenced by factors like usage frequency and quantity.  If you need to flush all the weed out of your system within 10 days, order a Test Clear Kit here, they work well and have great customer reviews.  But what is going on with your body and why does your body still have THC in it after smoking weed?

 

Cannabis comprises various compounds, notably tetrahydrocannabinol (THC) and cannabidiol (CBD). These substances bind to the same receptors as naturally occurring endocannabinoids, typically eliminated through urine and stool.

 

Detoxing from marijuana and managing cannabis use disorder involves a multifaceted approach. This includes goal setting with support, addressing withdrawal symptoms, managing physical and mental changes during detoxification, among other elements.

 

Given the individualized nature of substance use disorder, seeking professional addiction treatment is crucial. It allows for tailored detox strategies, managing potential side effects, handling marijuana overdose effects, and exploring diverse detox methodologies.

 

Understanding Marijuana Detox

 

Marijuana detox is the process of eliminating tetrahydrocannabinol (THC), marijuana’s psychoactive component, from the body. It is critical because THC can remain in the body’s fat cells even after marijuana usage has stopped, potentially resulting in positive drug test results or hampering efforts to achieve sobriety.

 

Marijuana detox is required to eliminate leftover THC from the system in those who are drug tested, such as sports, workers, or those in court. This protects against negative repercussions while also ensuring that testing protocols are followed.

 

The process of marijuana detox is essential to the goal of recovery. Removing THC from the body helps to terminate the cycle of reliance, lessen cravings, and make the road to recovery easier.

 

Additionally, persons suffering from marijuana-related health issues may require marijuana detox. Excessive or extended usage can be detrimental to both physical and mental health. Detoxification, which allows the body to rid itself of THC and its derivatives, may be able to mitigate any negative health consequences.  Could you pass a THC drug test with 2 hours notice? Let’s find out…

 

What’s the duration of cannabis presence in the body?

 

As per American Addiction Centers, here’s the estimated duration for cannabis detection:

 

Hair: Up to 90 days

Urine: 3 days to over a month, contingent on usage

– Saliva: Approximately 48 hours

– Blood: Roughly 36 hours

 

Moreover, a 2017 study found that cannabinoids may persist in sweat for 7–14 days.

 

The duration of these compounds in one’s system varies widely. Another 2017 study highlights that the strain of cannabis used is a significant factor. Different strains contain varying cannabinoid levels, influencing their presence in the body.

 

Usage frequency also plays a role. Prolonged cannabis use prolongs cannabinoid traces in the body. This implies potential positive tests months after cessation; some have tested positive for THC even 3 months post-discontinuation.

 

Other factors impacting cannabis detection duration include:

 

– Consumption volume

– Exercise frequency and type

– Dietary habits

– Metabolic rate

– Body fat percentage

 

Given these variables, pinpointing the exact duration of cannabis, particularly THC, in one’s system after use can be challenging.

 

Optimal Methods for Weed Detox

 

Detoxifying from marijuana is multifaceted, with no singular “hack” to navigate through withdrawal, cravings, and other challenges.

 

Achieving the best results in marijuana detox entails considering various factors. Effective marijuana detox involves:

 

1. Attending to physical well-being by addressing common symptoms like aches and pains during withdrawal.

2. Maintaining a balanced diet with ample water intake, consistent healthy meals, and avoiding stimulants like caffeine.

3. Prioritizing mental health care to manage emotional adjustments in brain chemistry, such as anxiety or depression.

4. Implementing strategies to prevent relapse and cope with cravings through support groups, therapy, or treatment centers.

5. Engaging in therapeutic activities to foster new interests and habits, often facilitated through outpatient programs or professional assistance.

 

There’s no shortcut to hasten marijuana detox. However, practices like hydration, nutrition, warm showers, and exercise can aid in physical comfort. Yet, the body and mind still require time to purge THC remnants.

 

Rather than expediting detox, it’s crucial to utilize this period with medical guidance to establish a foundation for relapse prevention and address withdrawal symptoms.

 

Though treatments and medical detox programs exist, there’s no quick fix or magic remedy to instantly eliminate marijuana from the system or pass drug tests.

 

Symptoms like red eyes can be alleviated with cold compresses and eye drops.

 

Natural detoxification remains the most effective approach. The liver plays a pivotal role in removing marijuana and other toxins. Maintaining overall health supports liver function, aiding in toxin elimination and restoring bodily balance.

 

Various products claim to assist individuals in eliminating cannabis traces from their bodies, available in forms such as:

 

– Tablets

– Capsules

– Mouthwashes

– Shampoos

 

However, the effectiveness of these detoxes may vary depending on the type of drug test undergone. For instance, detoxes targeting urine cleansing might not yield desired results and could even result in a contaminated urine sample.

 

This occurs because urine-focused detoxes operate by purging the kidneys. While eliminating THC, they may inadvertently remove creatine and diminish urine’s natural density. Consequently, these factors could lead to the test appearing contaminated, necessitating a repeat test.

 

The Importance of Professional Marijuana Detox

 

Seeking marijuana detox with medical oversight is essential for safety and efficacy. Healthcare experts can craft personalized detox strategies tailored to an individual’s unique requirements, objectives, and medical background. They oversee the detox process, offer guidance, and manage any potential complications.

 

Supervised detox guarantees appropriate support and care, with healthcare professionals recommending additional treatments or therapies to address withdrawal symptoms and underlying issues contributing to marijuana usage.

 

Furthermore, medical supervision ensures the individual’s safety throughout detoxification. Abrupt cessation of marijuana may induce withdrawal symptoms, potentially uncomfortable or harmful. Professionals can employ measures to mitigate these symptoms and advise on managing cravings for sustained abstinence.

 

Bottom Line

 

THC detoxification is a complex process influenced by individual factors like usage patterns and metabolism. While natural methods offer effectiveness, seeking professional medical guidance ensures personalized care and safety. From managing withdrawal symptoms to addressing underlying issues, professional supervision enhances the detox journey. Remember, there’s no instant solution for THC detox, but with patience, proper care, and professional support, individuals can navigate towards sobriety and improved well-being successfully. By understanding the importance of medical supervision, individuals can embark on a journey of detoxification with confidence, knowing they have the necessary tools and support to achieve their goals.

 

PASS A DRUG TEST YOU HAD NO IDEA WAS COMING, READ ON…

HOW TO PASS A DRUG TEST FAST

3 WAYS TO PASS A SURPRISE A DRUG TEST, READ THIS!



Source link

Continue Reading

Cannabis News

MedMen, The $1.7 Billion Apple Store of Weed, Goes Bankrupt Just as Marijuana Gets Rescheduled in America

Published

on

By


medmen goes bankrupt

MedMen Enterprises Inc. has admitted defeat, citing financial woes and an inability to settle its debts, revealed Amit Pandey, the former chief financial officer of the cannabis company, late Friday.

MedMen, once a celebrated pioneer in the cannabis industry and dubbed the ‘Apple store of weed,’ has been hit by a string of setbacks in recent years. These include financial woes, the shuttering of retail outlets, workforce reductions, legal battles, and internal disputes among top executives, all of which have led to the company’s current predicament.

In a press release issued on Friday, MedMen declared that they have carefully assessed the company’s and its subsidiaries’ current financial state. This assessment also includes their incapacity to meet financial obligations as they come and the imminent actions by secured creditors. To that end, they’ve reached the challenging decision to cease operations and initiate Bankruptcy Proceedings and Receivership Proceedings.”

Considering these factors and with no viable alternatives at hand, the Company’s board of directors concluded that proceeding with the Bankruptcy Proceedings and Receivership Proceedings was in the Company’s best interest,” the statement continued.

Here Are A Few Indications

Once revered as a titan in the cannabis industry, with a valuation soaring as high as $1.7 billion as a public entity, MedMen faced imminent financial collapse over a year ago, as revealed in a December 2022 regulatory filing with the Securities and Exchange Commission. At that time, the company possessed a mere $15.6 million in cash while grappling with a staggering $137.4 million debt load.

Following its initial financial struggles, MedMen faced a series of challenges. Store closures and inventory liquidation began in California, and the company defaulted on payments, leading to severed partnerships with major brands. Landlords demanded overdue rent payments. Amid this turmoil, top executives and board members started to depart, signaling deeper turmoil within the company, as the Green Market Report reported.

What Caused the Downfall?

The crux of the issue likely stems from the company’s swift expansion, driven by the initial excitement surrounding the 2018 legalization of cannabis in California. However, as is often the case nationwide, legalization marked just the beginning, leading to confrontations with the intricate realities of an industry rife with regulatory barriers, hefty taxes, and hampered by federal law.

Despite enjoying early triumphs, MedMen encountered a slew of obstacles, including legal disputes, unsuccessful acquisitions, and competition from both legal and underground cannabis markets.

Six years following an IPO that propelled its valuation to over $3 billion, MedMen, a cannabis retailer, now holds negligible value. Its recent bankruptcy filing in a California court signifies the final blow in a dramatic downfall for a company emblematic of the broader trials facing the legal cannabis sector.

“MedMen has been ‘DeadMen’ for many investors for quite some time,” remarked cannabis industry analyst Alan Brochstein to Fortune. “While this outcome may have been foreseeable to some, not everyone anticipated it.”

MedMen swiftly penetrated the legal cannabis scene following California’s legalization of recreational use in 2016. Initially lauded as the “Apple store of weed,” MedMen’s retail outlets boasted “sleek branding” and a “premium design aesthetic,” as outlined in a 2022 investor presentation.

To capitalize on the anticipated surge in legal cannabis demand, MedMen embarked on an ambitious expansion, opening upscale storefronts in prominent areas such as Venice Beach, New York’s Fifth Avenue, and near the Las Vegas Strip. Riding a wave of positive media coverage and public excitement surrounding legal cannabis, the company enjoyed significant attention.

Under the leadership of co-founder Adam Bierman, who launched the venture in his twenties, MedMen made its debut on the public market in 2018 at slightly above $3 per share. Investor enthusiasm drove its share price to double by the year’s end.

Buoyed by early triumphs, MedMen aimed for rapid growth, accumulating hundreds of millions in debt and pursuing an extensive $682 million merger with competitor PharmaCann. However, the merger collapsed following a Department of Justice announcement of an antitrust investigation, exacerbating MedMen’s financial woes.

As the broader cannabis market faced headwinds, compounded by concerns over regulatory scrutiny of hazardous vape cartridges, investor confidence waned, hindering MedMen’s ability to repay creditors. They went public in 2018. And by the time we reached 2020, [MedMen] was in big trouble, remarked Brochstein. They took on too much debt and made overzealous promises.”

Throughout 2019, MedMen’s stock plummeted, shedding 92% of its value as the company grappled with exorbitant tax obligations and struggled to compete against unlicensed sellers offering lower prices. The onset of the pandemic, however, triggered a surge in demand, providing MedMen and other cannabis retailers with a reprieve through 2020.

The cannabis industry did better than anybody would have expected in 2020. Despite this unexpected boon, it proved insufficient. At its peak, MedMen boasted 25 branches nationwide and had ambitious plans for international expansion. However, today, all but two locations have permanently shuttered.

Bierman, the co-founder, was ousted in early 2020 amidst a slew of high-profile lawsuits alleging racism, stock manipulation, and misuse of company funds to finance an extravagant lifestyle complete with private security and customized Cadillac Escalades.

A Fall From Grace

MedMen’s bankruptcy filing, unveiling over $400 million in liabilities, marks the final chapter in its stunning collapse. Hindered by steep interest rates and sour investor sentiment, the company could not refinance its debt, eventually ceasing SEC disclosures altogether.

“The capital markets were cut off for them so they couldn’t fix their old mistakes,” noted Brochstein.

The once-vibrant unicorn of the cannabis industry now stands bankrupt, with assets valued at a mere $1 (yes, just a dollar) and liabilities totaling $410 million, as detailed in the company’s bankruptcy documents. Predictably, MedMen’s shares, dormant for weeks, face imminent delisting following its steep downward spiral in 2024. At the start of this decline, the OTC Marketplace devalued the company to zero in January.

MedMen’s complete downfall serves as a sobering lesson in the ever-evolving cannabis sector, where once a fault appears, the entire structure can unravel swiftly.

 

MEDMEN BANKRUPTCY EXPLAINED, READ ON…

MEDMEN BANKRUPTCY PROCEEDING

FRANK SEGALL TALKS MEDMEN DISTRESSED DEBT!

 



Source link

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media